Skip to content

Vor Biopharma VOR Return on invested capital

Return on invested capital at other companies

Johnson & Johnson logo
Johnson & JohnsonJNJ
20.6%+0.3pp
Amgen logo
AmgenAMGN
14.1%+4.0pp
Vertex Pharmaceuticals logo
Vertex PharmaceuticalsVRTX
26.8%+23.0pp
Dianthus Therapeutics logo
Dianthus TherapeuticsDNTH
-35.2%-8.3pp
Design Therapeutics, Inc. logo
Design Therapeutics, Inc.DSGN
-37.1%+12.1pp
Cullinan Therapeutics, Inc. logo
Cullinan Therapeutics, Inc.CGEM
-58%+22.6pp

Other financials

Income statement

See full
Operating income-$35.2M-5.6%
Net income-$219.6M-576%
EPS (diluted)-$5.11+1.9%

Balance sheet

See full
Cash & equivalents$169.9M+239%
Total debt$2.9M-90.5%
Total equity-$150.4M-328%
Total assets$506.7M+364%

Cash flow

See full
Operating cash flow-$38.2M-23.1%
CapEx$48.0K-79.2%
Free cash flow-$38.3M-22.4%

Valuation

See full
Market cap$809M+2,594%
Enterprise value$642.06M+5,866%

Returns & leverage

See full
Return on equity-125.4%+671pp
Debt / equity0.5×+0.2×
Current ratio31.1×+27.3×

Where this comes from

Calculated from Vor Biopharma’s reported figures.

Based on trailing twelve months.

The official record: Vor Biopharma’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Vor Biopharma's return on invested capital.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Vor Biopharma's return on invested capital?
Vor Biopharma (VOR) reported return on invested capital of -153.1% in Q1 2025.
How has Vor Biopharma's return on invested capital changed year-over-year?
Vor Biopharma's return on invested capital decreased by 102.8% year-over-year, from -75.5% to -153.1%.
What does return on invested capital mean?
Net operating profit after tax (operating income taxed at the effective rate) divided by average invested capital (debt plus equity minus cash). Measures the after-tax return on all capital put to work in the business, independent of capital structure.